TRDA
Ticker
Entrada Therapeutics, Inc.
TRDA · Healthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…Entrada Therapeutics, Inc. (TRDA), in the Healthcare sector, has 20 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 2 purchases and 18 sales. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Sep 9 and filed Sep 9. The most active filer was Kush Parmar with 5 filings.
Add to watchlistFilings, ttm
20
2 buys · 18 sells
Traders, ttm
8
8 insiders
Volume, ttmiDollar value disclosed in the window
$15.8M
estimated for Congress, as filed for insiders
Median delay
3d
execution to disclosure
Last traded
Sep 9
Filed Sep 9
ADViAverage daily dollar volume
$2.8M
market data
Share price · 12M
$7.13 (+35.0%)
Adjusted for splits and dividends.
Volume by month
Buys $2.0M
Sells $18.9M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
KPRecent filings
Mpm Bioventures 2018, L.P.SALE
10% owner
$1.9M259,837 sh across 3 lots
Exec Sep 4
Filed Sep 9 · 7:24 PM ET MPM BioVentures 2014, L.P.SALE 10% owner $1.9M
259,837 sh across 3 lots
Exec Sep 4
Filed Sep 9 · 7:23 PM ET Mpm Bioventures 2018, L.P.SALE 10% owner $617K
86,482 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 7:21 PM ET MPM BioVentures 2014, L.P.SALE 10% owner $617K
86,482 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 7:21 PM ET Mpm Bioventures 2018, L.P.SALE 10% owner $590K
83,181 sh across 2 lots
Exec Aug 27
Filed Aug 31 · 6:26 PM ET MPM BioVentures 2014, L.P.SALE 10% owner $590K
83,181 sh across 2 lots
Exec Aug 27
Filed Aug 31 · 6:25 PM ET MPM BioVentures 2014, L.P.SALE 10% owner $462K
62,714 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 9:28 PM ET Mpm Bioventures 2018, L.P.SALE 10% owner $462K
62,714 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 9:27 PM ET Kush ParmarSALE Director $1.0M
144,761 sh across 2 lots
Exec Aug 7
Filed Aug 10 · 7:54 PM ET 5AM Ventures V, L.P.SALE 10% owner $358K
52,317 sh × $6.85
Exec Aug 7
Filed Aug 10 · 7:52 PM ET 5AM Ventures V, L.P.SALE 10% owner $795K
114,756 sh × $6.93
Exec Jul 30
Filed Aug 3 · 5:32 PM ET Kush ParmarSALE Director $795K
114,756 sh × $6.93
Exec Jul 30
Filed Aug 3 · 5:26 PM ET Nathan J DowdenSALE President & COO $230K
15,000 sh × $15.33
Exec May 4
Filed May 4 · 5:30 PM ET Natarajan SethuramanSALE President, Research & Develop. $399K
25,907 sh × $15.39
Exec May 4
Filed May 4 · 5:30 PM ET Kory James WentworthSALE Chief Financial Officer $148K
11,388 sh × $13.02
Exec Mar 10
Filed Mar 11 · 5:30 PM ET Nathan J DowdenSALE President & COO $155K
11,894 sh × $13.05
Exec Mar 10
Filed Mar 11 · 5:30 PM ET Baker Bros. Advisors LpPURCHASE 10% owner $240K
26,468 sh across 2 lots
Exec Nov 20 2025
Filed Nov 24 2025 · 4:09 PM ET 5AM Ventures V, L.P.SALE 10% owner $1.8M
200,000 sh × $8.80
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET Kush ParmarSALE Director $1.8M
200,000 sh × $8.80
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET Baker Bros. Advisors LpPURCHASE 10% owner $1.0M
137,124 sh across 3 lots
Exec Nov 10 2025
Filed Nov 12 2025 · 5:34 PM ET 5AM Opportunities I, L.P.SALE 10% owner $150K
20,065 sh × $7.50
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET Kush ParmarSALE Director $150K
20,065 sh × $7.50
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET Andrew J. SchwabSALE 10% owner $777K
112,156 sh across 4 lots
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET Kush ParmarSALE Director $777K
112,156 sh across 4 lots
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET Peter S KimPURCHASE Director $732K
50,000 sh across 2 lots
Exec May 13 2024
Filed Jun 18 2025 · 5:30 PM ET †